Palantir Technologies Inc (PLTR stock) price drops as a major institution issues a bold downgrade

NYSE:PLTR loses 4.63% to close the week as the broader markets pull back from their all-time highs.
Credit Suisse issues a bearish downgrade for Palantir.
It is not a completely negative report, but the new price target sees a near 40% downside from current levels.

NYSE:PLTR has been one of many successful IPOs that have hit the public markets this year, although the company has yet to see sky-high price levels that other debuts like Snowflake (NYSE:SNOW) or AirBnb (NASDAQ:ABNB) have seen. On Friday, shares dropped 4.63% to close the trading week at $25.97 as the broader markets saw a pullback after hitting all-time highs earlier in the week. Palantir is still up over 185% since its debut at the end of September. But one analyst does have an issue with the high valuation at which Palantir is currently trading.

That analyst is Brad Zelnick of Credit Suisse who stated that Palantir’s current valuation is “disconnected from its fundamentals” and that there may be some downside potential brewing. Zelnick downgraded the status of the stock to an underperform rating while raising the price target from $13 to $17, a fairly shocking number to investors which shows a near 40% drop from Friday’s closing price. Zelnick does reiterate that Palantir does offer a very unique data analytics platform but maintains that in its current state, the valuation does not match the baseline fundamentals of the stock.

Palantir stock price

The IPO lockup period for Palantir is also quickly approaching as insiders are able to sell their shares near the middle of February in 2021. While this is not always a contributing factor to the stock’s price, any sort of sell-off will result in a dilution of current shares. Zelnick’s report does seem negative, but investors need to remember that analyst upgrades and downgrades are just their opinion and not a definite outlook on how the stock will continue to perform.

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.